Skip to main content
. 2019 Jan 23;4(2):136–143. doi: 10.1001/jamacardio.2018.4615

Table 2. Demographic and Clinical Characteristics of the PheWAS Analytic Data Set by Tertile of International Thyrotropin Polygenic Risk Score.

Variable No. (%)
Lowest GRS Tertile Middle GRS Tertile Highest GRS Tertile
No. 12 378 12 409 12 366
Male, No. (%) 6399 (51.7) 6444 (51.9) 6487 (52.5)
Birth, median (IQR), y 1945 (1935-1955) 1945 (1935-1955) 1945 (1935-1955)
Patients with at least 1 phecodea,b
Atrial fibrillation and/or flutter (phecode 427.2) 2712 (33.9) 2580 (32.3) 2500 (31.5)
Nonhypertensive congestive heart failure (phecode 428) 2832 (26.6) 2775 (26.1) 2702 (25.5)
Hypertension (phecode 401) 8725 (70.5) 8773 (70.7) 8639 (69.9)
Ischemic heart disease (phecode 411) 4887 (41.4) 4914 (41.4) 4954 (41.9)
Ventricular tachycardia (phecode (427.12) 805 (12.9) 758 (12.0) 680 (10.8)
Diabetes (phecode 250) 4205 (38.7) 4067 (37.3) 4064 (37.5)
Hypothyroidism (phecode 244) 2264 (19.7) 2461 (21.1) 2613 (22.5)
Thyrotoxicosis with/without goiter (phecode 242) 516 (5.3) 452 (4.7) 424 (4.5)
Nontoxic nodular thyroid goiter (phecode 241) 784 (7.8) 690 (7.0) 515 (5.4)

Abbreviations: GRS, polygenic risk score; IQR, for interquartile range; PheWAS, phenome-wide association study.

a

Percentages of individuals with a diagnosis are based on the counts of cases and controls, and counts will differ for each phenotype.

b

PheWAS uses International Classification of Diseases codes to define a set of computable phenotypes or phecodes defined and validated by experts using a combination of International Classification of Diseases codes.8